P

Personalis

PSNL

3.56000
USD
0.1
(2.89%)
Market Open
Volume
12,843
EPS
0
Div Yield
0
P/E
-3
Market Cap
310,555,654
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
BMY
0.620
(1.30%)
48.180 USD
GSK
0.865
(2.23%)
39.650 USD
MRNA
-25.020
(-20.99%)
94.160 USD
PFE
0.115
(0.38%)
30.650 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: Personalis

Sector: Healthcare
Industry: Diagnostics & Research
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.